Results 211 to 220 of about 1,882,229 (349)

EPSTEIN-BARR VIRUS (EBV) INFECTION OF EPITHELIAL CELLS FROM THE NASOPHARYNX

open access: bronze, 1979
Toru Takimoto   +3 more
openalex   +2 more sources

Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD)

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Adverse immuno‐inflammatory responses possibly influenced by bacterial compounds reaching the liver as a consequence of altered intestinal permeability appear to be crucial in the pathogenesis of drug‐induced liver injury and steatotic liver diseases.
Daniel E. Di Zeo‐Sánchez   +10 more
wiley   +1 more source

The PD-1/PD-L1 pathway and Epstein-Barr virus. [PDF]

open access: yesEur J Med Res
Wang H   +5 more
europepmc   +1 more source

Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis

open access: yes
Australasian Journal of Dermatology, EarlyView.
Mizuho Namba   +6 more
wiley   +1 more source

T cells from newly diagnosed multiple sclerosis patients have enhanced responsiveness to CD46 activation

open access: yesClinical and Experimental Neuroimmunology, EarlyView.
Abstract Objective To evaluate the responsiveness of T cells from newly diagnosed multiple sclerosis (MS) patients to CD46 co‐stimulation, a membrane co‐factor protein potentially involved in MS pathogenesis. Methods T cells from MS patients and non‐diseased symptomatic controls (SC) were activated in vitro with or without αCD46 antibody co‐stimulation.
Linda Sundvall   +6 more
wiley   +1 more source

The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases. [PDF]

open access: yesMedicina (Kaunas)
Morawiec N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy